Opioid Sensitivity in Children with and without Obstructive Sleep Apnea

Area of Science:

• Anesthesiology
• Pediatric Pharmacology
• Sleep Medicine

Background:

• Opioids are frequently used for pain relief during surgery.
• Concerns exist regarding increased opioid sensitivity and respiratory risks in children with obstructive sleep apnea (OSA).
• Previous assumptions about heightened opioid effects in pediatric OSA patients lack rigorous testing.

Purpose of the Study:

• To investigate if children with obstructive sleep apnea exhibit increased pharmacodynamic sensitivity to remifentanil.
• To compare the miotic and respiratory depressant effects of remifentanil in children with and without OSA.

Main Methods:

• Administered fixed-rate remifentanil infusions to children aged 8-14 years with or without OSA.
• Measured plasma remifentanil concentrations using liquid chromatography-mass spectrometry.
• Assessed remifentanil effects by monitoring miosis, respiratory rate, and end-expired carbon dioxide.

Main Results:

• Remifentanil induced miosis in both groups without significant differences in the concentration-effect relationship.
• No significant alterations in respiratory rate or end-expired carbon dioxide were observed in either group.
• The tested doses of remifentanil did not differentially affect ventilatory parameters based on OSA status.

Conclusions:

• Children with obstructive sleep apnea do not display increased sensitivity to the miotic effects of remifentanil.
• Remifentanil administration did not impact respiratory parameters differently in children with or without OSA.
• The findings challenge prior assumptions regarding heightened opioid sensitivity in pediatric OSA.